Literature DB >> 19064958

Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate.

Noah M Hahn1, Maria Reckova, Liang Cheng, Lee Ann Baldridge, Oscar W Cummings, Christopher J Sweeney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19064958     DOI： 10.1200/JCO.2008.19.9380

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience.

Authors:  Montserrat Ayala-Ramirez; Lei Feng; Mouhammed A Habra; Thereasa Rich; Paxton V Dickson; Nancy Perrier; Alexandria Phan; Steven Waguespack; Shreyaskumar Patel; Camilo Jimenez
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

Review 2.  Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.

Authors:  Svenja Nölting; Ashley B Grossman
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

3.  Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.

Authors:  Judith Favier; Peter Igaz; Nelly Burnichon; Laurence Amar; Rossella Libé; Cécile Badoual; Frédérique Tissier; Jérôme Bertherat; Pierre-François Plouin; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

Review 4.  Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.

Authors:  Judith Favier; Laurence Amar; Anne-Paule Gimenez-Roqueplo
Journal:  Nat Rev Endocrinol       Date:  2014-11-11       Impact factor: 43.330

5.  Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.

Authors:  Montserrat Ayala-Ramirez; Cecile N Chougnet; Mouhammed Amir Habra; J Lynn Palmer; Sophie Leboulleux; Maria E Cabanillas; Caroline Caramella; Pete Anderson; Abir Al Ghuzlan; Steven G Waguespack; Desirée Deandreis; Eric Baudin; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2012-09-10       Impact factor: 5.958

6.  Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid.

Authors:  Yang Liu; Ying Pang; Chunzhang Yang; Karel Pacak; Boqun Zhu; Ondrej Uher; Veronika Caisova; Thanh-Truc Huynh; David Taieb; Katerina Hadrava Vanova; Hans Kumar Ghayee; Jiri Neuzil; Mark Levine
Journal:  Clin Cancer Res       Date:  2020-03-09       Impact factor: 12.531

7.  Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma.

Authors:  Carla Vaz Ferreira; Débora Rodrigues Siqueira; Mírian Romitti; Lucieli Ceolin; Beatriz Assis Brasil; Luise Meurer; Clarissa Capp; Ana Luiza Maia
Journal:  Int J Mol Sci       Date:  2014-03-26       Impact factor: 5.923

8.  Sunitinib as Neoadjuvant Chemotherapy in the Management of Metastatic Renal Cell Carcinoma Mimicking a Glomus Vagale Tumor in the Head and Neck: A Case Report and Review of Literature.

Authors:  Serkan Erkan; Jessica Somner; Gunesh P Rajan
Journal:  J Neurol Surg Rep       Date:  2016-06

9.  Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma.

Authors:  Gabriele Parenti; Benedetta Zampetti; Elena Rapizzi; Tonino Ercolino; Valentino Giachè; Massimo Mannelli
Journal:  J Oncol       Date:  2012-07-17       Impact factor: 4.375

10.  Sunitinib Treatment for Advanced Paraganglioma: Case Report of a Novel SDHD Gene Mutation Variant and Systematic Review of the Literature.

Authors:  Franz Sesti; Tiziana Feola; Giulia Puliani; Roberta Centello; Valentina Di Vito; Oreste Bagni; Andrea Lenzi; Andrea M Isidori; Vito Cantisani; Antongiulio Faggiano; Elisa Giannetta
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.